Psychedelics for Alcoholism, Q&A with Clearmind Management

March 30, 2022 - Virtual Event

Leaders, innovators, scientists, doctors, patients, enthusiasts,  and dignitaries in the psychedelic space are invited to attend a virtual Q&A session by the Clearmind Management,  focused on the potential treatment of alcohol use and binge drinking based on its psychoactive molecule MEAI, on March 30, 2022.

Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the “Company“), is a psychedelic medicine biotech company engaged in the discovery and development of novel psychedelic-derived therapeutics. Adi Zuloff-Shani, PhD, Clearmind’s Chief Executive Officer, will discuss the various possibilities of therapeutics development for excessive alcohol consumption and related mental disorders,  in heavily regulated environments.

Visionaries and innovators in the psychedelic space will discuss the psychedelic therapies and treatments for excessive alcohol consumption and mental disorders based on its Psychoactive Molecule MEAI.  The expert panel at Clearmind ManAgement will solve user queries and discuss the therapeutic treatments of excess alcohol use and mental disorders.

For more information, please visit

Conference Highlights
  • The Psychedelics for Alcoholism, Q&A with Clearmind Management will be held on March 30, 2022.
  • This interactive Q&A session is focused on the potential treatment of excessive alcohol use disorder based on its Psychoactive Molecule MEAI.
  • Clearmind Medicine Inc. is a biotech company engaged in the development of novel psychedelic-derived therapeutics.

Event Website

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717

View All Solutions

You’re already more familiar with brand awareness than you might think. What’s your favorite brand of soft drink, athletic shoe, car, shampoo, streaming content provider? Chances are, you first tried those brands because of their awareness strategies. Whether it was word of mouth or a TV commercial, Facebook post, billboard or coupon, that awareness peaked interest, triggered a purchase reaction, and ideally built customer loyalty.

More About Brand Awareness

5,000+ key syndication outlets across the country. IBN’s extensive system of strategic distribution points maximizes your exposure to an audience of millions, including journalists, investors, day traders, fund managers and a multitude of other interested individuals. Now your press releases, earnings statements, branded articles, shareholder updates, corporate achievements can reach a vast and diverse nationwide audience.

More About InvestorWire

Make sure your message resonates. IBN integrates social media with traditional distribution channels to make sure your message resonates long after initial publication. This innovative model ensures that your news not only crosses the wire, but keeps reverberating via social conversation on Twitter, Facebook, LinkedIn and other social networks.

More About Social MediaIBN Social Media NetworkSocial Media Statistics & FAQs

A unique format with a traditionally different sensory input – hearing.As conferences and events continue to suffer cancellations and greatly reduced attendance, many businesses are wondering how to network with large investor audiences in the new normal. At the same time podcasts have seen a jump in popularity.

More About IBN Podcast Solutions